1. Home
  2. AWRE vs SLGL Comparison

AWRE vs SLGL Comparison

Compare AWRE & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aware Inc.

AWRE

Aware Inc.

HOLD

Current Price

$1.96

Market Cap

44.5M

Sector

Technology

ML Signal

HOLD

Logo Sol-Gel Technologies Ltd.

SLGL

Sol-Gel Technologies Ltd.

HOLD

Current Price

$42.30

Market Cap

117.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AWRE
SLGL
Founded
1986
1997
Country
United States
Israel
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.5M
117.8M
IPO Year
1996
2018

Fundamental Metrics

Financial Performance
Metric
AWRE
SLGL
Price
$1.96
$42.30
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$50.00
AVG Volume (30 Days)
32.0K
16.6K
Earning Date
10-29-2025
11-20-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$17,428,000.00
$18,970,000.00
Revenue This Year
N/A
$121.82
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.72
62.04
52 Week Low
$1.37
$4.02
52 Week High
$2.95
$52.26

Technical Indicators

Market Signals
Indicator
AWRE
SLGL
Relative Strength Index (RSI) 30.88 52.92
Support Level $1.99 $40.10
Resistance Level $2.09 $44.99
Average True Range (ATR) 0.09 3.44
MACD -0.01 -0.10
Stochastic Oscillator 0.03 55.31

Price Performance

Historical Comparison
AWRE
SLGL

About AWRE Aware Inc.

Aware Inc is a provider of software and services to the biometrics industry. The company's software products are used in government and commercial biometrics systems to identify or authenticate people. The government applications of biometrics systems include border control, visa applicant screening, law enforcement, national defense, intelligence, secure credentialing, access control, and background checks. Its commercial applications include user authentication for login to mobile devices, computers, networks, and software programs, user authentication for financial transactions and purchases. Its geographical segments include the United States, the United Kingdom, and the Rest of the world, out of which it derives maximum revenue from United States.

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

Share on Social Networks: